EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Centralized rapid genetic diagnosis of combined immunodeficiency in Japan

Tamaki Kato iD, Yumi Ogura, Chikako Kamae, Tzu-Wen Yeh, Tsubasa Okano, Junya Take, Kanako Mitsui-Sekinaka, Kunihiko Moriya iD, Janine Reichenbach iD, Pandiarajan Vignesh iD, Amit Rawat, Surjit Singh und 6 weitere

Pediatrics International · 2025-01 · 67 (1)

DOI: 10.1111/ped.70085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 03.06.2025. Verfasst von Tamaki Kato und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, National Defense Medical College, Saitama, Japan. Hauptthemen laut MEDLINE: Severe Combined Immunodeficiency, Genetic Testing, Ataxia Telangiectasia. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Program for Intractable Diseases Research utilizing Disease-specific iPS cells of Japan Agency for Medical Research and Development (AMED), the Ministry of Health, Labour and Welfare, a grant from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Severe combined immunodeficiency (SCID) is a pediatric emergency, and rapid genetic diagnosis is necessary for proper patient management, leading to successful stem cell transplantation and gene therapy. Ataxia telangiectasia (AT) requires early diagnosis to prevent infectious diseases and early detection of cancer. We aimed to diagnose patients with SCID/AT as quickly as possible and link them to the best treatments via the primary immunodeficiency database in Japan (PIDJ) network.

Methods

For 111 patients with suspected combined immunodeficiency, including SCID/AT, we analyzed T‐cell receptor excision circle (TREC) and sequenced 29 causative genes of SCID, including ATM, by ion semiconductor sequencing using multiplex polymerase chain reaction amplicons. In some cases, DNA extracted from dried blood spots was used for the analysis.

Results

Approximately 70.8% of 0–1‐year‐old patients and 26.5% of the patients >2 years old with low TREC were diagnosed genetically, including ADA , ATM , IL2RG , IL7R , JAK3 , RAG1 , RAG2 , DCLRE1C , NHEJ1 , and LIG4 . However, only 6.9% of patients with normal TREC were genetically diagnosed ( STIM1 and ATM ) in our panel. In Japan, all patients had been genetically diagnosed after infection or other life‐threatening conditions, and >80% of patients are linked to appropriate treatment after diagnosis.

Conclusions

Target gene sequencing, including SCID and AT genes, was useful for the diagnosis of patients with combined immunodeficiency with low TREC and to lead them to prompt treatment and better prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Severe Combined ImmunodeficiencyGenetic TestingAtaxia TelangiectasiaHumansJapanMaleInfantChildChild, PreschoolFemaleInfant, NewbornAdolescent

Stichwörter der Autor:innen

T‐cell receptor excision circleataxia telangiectasiacombined immunodeficiencynext generation sequencersevere combined immunodeficiency

Autor:innen und Institutionen

  • Department of Pediatrics, National Defense Medical College, Saitama, Japan.
  • Department of Pediatrics and Developmental Biology, Institute of Science Tokyo, Tokyo, Japan.
  • Department of Immunology, University Children's Hospital Zurich, Zurich, Switzerland.
  • Allergy Immunology Unit, Advanced Pediatrics Center, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Child Health and Development, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
  • Department of Applied Genomics, Kazusa DNA Research Institute, Chiba, Japan.

ORCID-Profile: Tamaki Kato, Kunihiko Moriya, Janine Reichenbach, Pandiarajan Vignesh, Masatoshi Takagi, Hirokazu Kanegane, Tomohiro Morio, Osamu Ohara, Kohsuke Imai, Shigeaki Nonoyama

Förderung

  • The Program for Intractable Diseases Research utilizing Disease-specific iPS cells of Japan Agency for Medical Research and Development (AMED)
  • the Ministry of Health, Labour and Welfare
  • a grant from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)
  • the Practical Research Project for Rare/Intractable Diseases of AMED
  • Japan Agency for Medical Research and Development
  • Ministry of Health, Labour and Welfare
  • Ministry of Education, Culture, Sports, Science and Technology

Zitieren

APA

Kato, T., Ogura, Y., Kamae, C., Yeh, T. W., Okano, T., Take, J., Mitsui-Sekinaka, K., Moriya, K., Reichenbach, J., Vignesh, P., Rawat, A., Singh, S., Takagi, M., Kanegane, H., Morio, T., Ohara, O., Imai, K., & Nonoyama, S. (2025). Centralized rapid genetic diagnosis of combined immunodeficiency in Japan. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70085

Vancouver

Kato T, Ogura Y, Kamae C, Yeh TW, Okano T, Take J, et al. Centralized rapid genetic diagnosis of combined immunodeficiency in Japan. Pediatrics International. 2025;67(1). doi:10.1111/ped.70085

BibTeX
@article{Kato2025,
  author = {Kato, Tamaki and Ogura, Yumi and Kamae, Chikako and Yeh, Tzu-Wen and Okano, Tsubasa and Take, Junya and Mitsui-Sekinaka, Kanako and Moriya, Kunihiko and Reichenbach, Janine and Vignesh, Pandiarajan and Rawat, Amit and Singh, Surjit and Takagi, Masatoshi and Kanegane, Hirokazu and Morio, Tomohiro and Ohara, Osamu and Imai, Kohsuke and Nonoyama, Shigeaki},
  title = {Centralized rapid genetic diagnosis of combined immunodeficiency in Japan},
  journal = {Pediatrics International},
  year = {2025},
  volume = {67},
  number = {1},
  doi = {10.1111/ped.70085}
}
Kostenlos starten →